# The Use of Tadalafil in Confirmed COVID-19 Pneumonia.

> **NCT04946162** · PHASE4 · WITHDRAWN · sponsor: **Santa Barbara Cottage Hospital**

## Conditions studied

- COVID
- Sars-CoV2
- ARDS, Human

## Interventions

- **DRUG:** Tadalafil Pill

## Key facts

- **NCT ID:** NCT04946162
- **Lead sponsor:** Santa Barbara Cottage Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-04-20
- **Primary completion:** 2020-04-20
- **Final completion:** 2020-04-20
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The investigators never completed the IRB application due to decrease in need to conduct the study.
- **Last updated:** 2021-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04946162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04946162, "The Use of Tadalafil in Confirmed COVID-19 Pneumonia.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04946162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*